Deborah J G Mackay,Gabriella Gazdagh,David Monk,Frederic Brioude,Eloise Giabicani,Izabela M Krzyzewska,Jennifer M Kalish,Saskia M Maas,Masayo Kagami,Jasmin Beygo,Tiina Kahre,Jair Tenorio-Castano,Laima Ambrozaitytė,Birutė Burnytė,Flavia Cerrato,Justin H Davies,Giovanni Battista Ferrero,Olga Fjodorova,Africa Manero-Azua,Arrate Pereda,Silvia Russo,Pierpaola Tannorella,Karen I Temple,Katrin Õunap,Andrea Riccio,Guiomar Perez de Nanclares,Eamonn R Maher,Pablo Lapunzina,Irène Netchine,Thomas Eggermann,Jet Bliek,Zeynep Tümer

Abstract:Background: Imprinting disorders are rare diseases resulting from altered expression of imprinted genes, which exhibit parent-of-origin-specific expression patterns regulated through differential DNA methylation. A subgroup of patients with imprinting disorders have DNA methylation changes at multiple imprinted loci, a condition referred to as multi-locus imprinting disturbance (MLID). MLID is recognised in most but not all imprinting disorders and is also found in individuals with atypical clinical features; the presence of MLID often alters the management or prognosis of the affected person. Some cases of MLID are caused by trans-acting genetic variants, frequently not in the patients but their mothers, which have counselling implications. There is currently no consensus on the definition of MLID, clinical indications prompting testing, molecular procedures and methods for epigenetic and genetic diagnosis, recommendations for laboratory reporting, considerations for counselling, and implications for prognosis and management. The purpose of this study is thus to cover this unmet need. Methods: A comprehensive literature search was conducted resulting in identification of more than 100 articles which formed the basis of discussions by two working groups focusing on clinical diagnosis (n = 12 members) and molecular testing (n = 19 members). Following eight months of preparations and regular online discussions, the experts from 11 countries compiled the preliminary documentation and determined the questions to be addressed during a face-to-face meeting which was held with the attendance of the experts together with four representatives of patient advocacy organisations. Results: In light of available evidence and expert consensus, we formulated 16 propositions and 8 recommendations as interim guidance for the clinical and molecular diagnosis of MLID. Conclusions: MLID is a molecular designation, and for patients with MLID and atypical phenotypes, we propose the alternative term multi-locus imprinting syndrome. Due to the intrinsic variability of MLID, the guidelines underscore the importance of involving experts from various fields to ensure a confident approach to diagnosis, counselling, and care. The authors advocate for global, collaborative efforts in both basic and translational research to tackle numerous crucial questions that currently lack answers, and suggest reconvening within the next 3-5 years to evaluate the research advancements and update this guidance as needed.

Comprehensive molecular and clinical findings in 29 patients with multi-locus imprinting disturbance

Multi-locus imprinting disturbance (MLID): interim joint statement for clinical and molecular diagnosis

Clinical and Molecular Diagnosis of Beckwith-Wiedemann Syndrome with Single- or Multi-Locus Imprinting Disturbance

Germline variants in genes of the subcortical maternal complex and Multilocus Imprinting Disturbance are associated with miscarriage/infertility or Beckwith–Wiedemann progeny

Quantitative DNA Methylation Analysis and Epigenotype-Phenotype Correlations in Taiwanese Patients with Silver-Russell Syndrome

Diagnosis of Prader-Willi syndrome and Angelman syndrome by targeted nanopore long-read sequencing

Rapid Diagnosis of Imprinting Disorders Involving Copy Number Variation and Uniparental Disomy Using Genome-Wide SNP Microarrays

Kagami Ogata syndrome: a small deletion refines critical region for imprinting

NanoImprint: A DNA methylation tool for clinical interpretation and diagnosis of common imprinting disorders using nanopore long‐read sequencing

Epigenetic profiling of the H19 differentially methylated region and comprehensive whole genome array‐based analysis in Silver–Russell syndrome

Variably methylated regions in the newborn epigenome: environmental, genetic and combined influences

Epigenetic Profiling of the H19 Differentially Methylated Region and Comprehensive Whole Genome Array-Based Analysis in Silver-Russel Syndrome

High-Resolution Analyses Of Epigenetic Aberrations In Myelodysplastic Syndrome

DNA methylation profiling in Kabuki syndrome: reclassification of germline KMT2D VUS and sensitivity in validating postzygotic mosaicism

Identification of Novel Mendelian Disorders of the Epigenetic Machinery (Mdems)-Associated Functional Mutations and Neurodevelopmental Disorders.

MSL2 variants lead to a neurodevelopmental syndrome with lack of coordination, epilepsy, specific dysmorphisms, and a distinct episignature

Consortium Profile: The Methylation, Imaging and NeuroDevelopment (MIND) Consortium

Identification of the DNA methylation signature of Mowat-Wilson syndrome

Genome-wide DNA Methylation Analysis in Families with Multiple Individuals Diagnosed with Schizophrenia and Intellectual Disability.

Assessment of 2q23.1 Microdeletion Syndrome Implicates MBD5 As a Single Causal Locus of Intellectual Disability, Epilepsy, and Autism Spectrum Disorder

Quantitative DNA Methylation Analysis and Epigenotype-Phenotype Correlations in Taiwanese Patients with Beckwith-Wiedemann Syndrome